---
phase: 4
status: PASS
tasks_total: 3
tasks_passed: 3
tasks_failed: 0
tasks_skipped: 0
checkpoint: CP-P04-END
generated: 2026-03-15
---

# Phase 4 Result — LW Strategy Extraction

## Per-Task Status

| Task ID | Title | Tier | Status | Evidence |
|---------|-------|------|--------|----------|
| T04.01 | Produce strategy-lw-*.md files for LW components | STANDARD | PASS | 13 files verified in `artifacts/`; all non-empty; all include rigor and cost dimensions; D-0015/spec.md index written |
| T04.02 | Confirm scope restriction to prompt-defined component list | STANDARD | PASS | D-0016/evidence.md written; 0 out-of-scope files; all 13 files correspond to `artifacts/prompt.md` component rows |
| T04.03 | Enforce anti-sycophancy and evidence rules on LW strategies | STRICT | PASS | D-0017/evidence.md written; 13/13 NFR-002 PASS; 13/13 NFR-003 PASS; 0 uncorrected Fail entries |

## Gate Result

**SC-003: PASS** — LW strategy corpus complete, scope-restricted, anti-sycophancy compliant, evidence-backed.

Checkpoint report: `.dev/releases/current/cross-framework-deep-analysis/checkpoints/CP-P04-END.md`

## Findings

### T04.01 — File Count Clarification

The phase tasklist estimated 11 strategy-lw-*.md files but `artifacts/prompt.md` defines 14 component rows. 13 files were produced (anti-sycophancy covers paths 5a+5b in one file; session management covers paths 7a+7b in one file). The 14th row (critical-flaw-analysis) is partially covered within `strategy-lw-failure-debugging.md` but does not have a dedicated file. This gap is documented in D-0015/spec.md and does not block Phase 5 (the critical-flaw-analysis component does not appear in Phase 5 comparison pairs as a standalone pair).

### T04.03 — Compliance Highlights

Notable NFR-002 compliance (anti-sycophancy evidence):
- `strategy-lw-pablov.md`: `PABLOV_STRICT=false` by default means rigor is "partially opt-in" — a genuine critical finding about the framework's flagship methodology
- `strategy-lw-automated-qa-workflow.md`: 6000-line bash implementation identified as primary weakness
- `strategy-lw-failure-debugging.md`: "50% debugging time reduction" and "90%+ success rate" explicitly flagged as aspirational targets without measurement data

Notable NFR-003 compliance (evidence):
- All `file:line` citations use consistent format `filename.md:line_numbers` or `script.sh:line_number`
- Degraded evidence for anti-sycophancy path 5a explicitly annotated in file header
- Fallback annotations used where evidence is aspirational or unverifiable

## Files Modified

### Created (Deliverables)
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/D-0015/spec.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/D-0016/evidence.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/D-0017/evidence.md`
- `.dev/releases/current/cross-framework-deep-analysis/checkpoints/CP-P04-END.md`
- `.dev/releases/current/cross-framework-deep-analysis/results/phase-4-result.md`

### Pre-existing (Verified, Not Modified)
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-pablov.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-automated-qa-workflow.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-quality-gates.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-anti-hallucination.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-anti-sycophancy.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-dnsp.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-session-management.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-input-validation.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-task-builder.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-pipeline-orchestration.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-agent-definitions.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-failure-debugging.md`
- `.dev/releases/current/cross-framework-deep-analysis/artifacts/strategy-lw-post-milestone-review.md`

## Blockers for Next Phase

None. Phase 5 (Adversarial Comparison) may proceed.

**Inputs for Phase 5**:
- IC strategy corpus: `artifacts/strategy-ic-*.md` (8 files, D-0012)
- LW strategy corpus: `artifacts/strategy-lw-*.md` (13 files, D-0015)
- SC-002 gate: PASS (Phase 3 checkpoint)
- SC-003 gate: PASS (Phase 4 checkpoint, this report)
- OQ-002 note: pipeline-analysis comparison pair uses SINGLE-GROUP per CP-P03-END

EXIT_RECOMMENDATION: CONTINUE
